May 9, 2011 – IBA announced today at the European Society for Therapeutic Radiology and Oncology conference that it has signed an agreement with Axios Oncology for the worldwide distribution of the company’s radiation therapy software solutions, RadCheck and BrachyCheck. With the addition of this software suite to its product portfolio, IBA offers enhanced solutions for radiation therapy to address quality assurance and patient safety needs.
RadCheck and BrachyCheck are software solutions for standalone dose verification of independent monitor units calculations in external beam radiation therapy and of calculations in brachytherapy. The software suite provides simple tools that enable pre-treatment verification of plans and thereby reinforces hospital and clinic quality assurance programs. IBA will distribute the products to its customers and to radiation therapy vendors worldwide through its international sales and marketing network.
“There is an increasing awareness from both patients and oncologists about the aspect of patient safety and how secondary checks in radiation therapy can be a crucial supporting element in avoiding errors,” said Juan Carlos Celi, M.D., vice president strategic business development, IBA.
For more information: www.iba-dosimetry.com.
April 10, 2026 
